IceCure Medical Ltd
IceCure Medical Ltd (ICCM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
iccm · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for IceCure Medical Ltd (ICCM) measures how much investors pay for each dollar of the company's trailing earnings. ICCM's current PE ratio of N/A is calculated by dividing its stock price of $3.64 by its TTM earnings per share of -$6.42.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
IceCure Medical LtdYou ICCM | $8M | N/A | — | -$6.42 |
 Baird Medical Investment Holdings Limited BDMD | $52M | N/A | — | -$0.98 |
 Cytosorbents Corporation CTSO | $26M | N/A | — | -$0.13 |
 electroCore, Inc. ECOR | $80M | N/A | — | -$1.65 |
 Spectral AI, Inc. MDAI | $59M | N/A | — | -$0.29 |
 Medicus Pharma Ltd. Common Stock MDCX | $7M | N/A | — | -$1.47 |
 PetMed Express, Inc. PETS | $36M | N/A | — | -$2.74 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-7.10 | — | |
2024-12-31 FY2024 | — | $-9.03 | — | |
2023-12-31 FY2023 | — | $-9.63 | — | |
2022-12-31 FY2022 | — | $-13.95 | — | |
2021-12-31 FY2021 | — | $-10.58 | — | |
2020-12-31 FY2020 | — | $-8.37 | — | |
2019-12-31 FY2019 | — | $-10.48 | — | |
2018-12-31 FY2018 | — | $-9.09 | — | |
2017-12-31 FY2017 | — | $-13.78 | — | |
2016-12-31 FY2016 | — | $-18.51 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for IceCure Medical Ltd (ICCM) measures how much investors pay for each dollar of the company's trailing earnings. ICCM's current PE ratio of N/A is calculated by dividing its stock price of $3.64 by its TTM earnings per share of -$6.42.
Frequently asked questions
ICCM pe ratio · 6 questionsICCM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.64 and TTM EPS of -$6.42. Data sourced from Financial Modeling Prep via ICCM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · IceCure Medical Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09